Literature DB >> 24460283

Attributable causes of liver cancer mortality and incidence in china.

Jin-Hu Fan1, Jian-Bing Wang, Yong Jiang, Wang Xiang, Hao Liang, Wen-Qiang Wei, You-Lin Qiao, Paolo Boffetta.   

Abstract

OBJECTIVES: To estimate the proportion of liver cancer cases and deaths due to infection with hepatitis B virus (HBV), hepatitis C virus (HCV), aflatoxin exposure, alcohol drinking and smoking in China in 2005. STUDY
DESIGN: Systemic assessment of the burden of five modifiable risk factors on the occurrence of liver cancer in China using the population attributable fraction.
METHODS: We estimated the population attributable fraction of liver cancer caused by five modifiable risk factors using the prevalence data around 1990 and data on relative risks from meta-analyses, and large-scale observational studies. Liver cancer mortality data were from the 3rd National Death Causes Survey, and data on liver cancer incidence were estimated from the mortality data from cancer registries in China and a mortality/incidence ratio calculated.
RESULTS: We estimated that HBV infection was responsible for 65.9% of liver cancer deaths in men and 58.4% in women, while HCV was responsible for 27.3% and 28.6% respectively. The fraction of liver cancer deaths attributable to aflatoxin was estimated to be 25.0% for both men and women. Alcohol drinking was responsible for 23.4% of liver cancer deaths in men and 2.2% in women. Smoking was responsible for 18.7% and 1.0% . Overall, 86% of liver cancer mortality and incidence (88% in men and 78% in women) was attributable to these five modifiable risk factors.
CONCLUSIONS: HBV, HCV, aflatoxin, alcohol drinking and tobacco smoking were responsible for 86% of liver cancer mortality and incidence in China in 2005. Our findings provide useful data for developing guidelines for liver cancer prevention and control in China and other developing countries.

Entities:  

Mesh:

Year:  2013        PMID: 24460283     DOI: 10.7314/apjcp.2013.14.12.7251

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  48 in total

1.  Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population.

Authors:  Xing Liu; Aileen Baecker; Ming Wu; Jin-Yi Zhou; Jie Yang; Ren-Qiang Han; Pei-Hua Wang; Zi-Yi Jin; Ai-Min Liu; Xiaoping Gu; Xiao-Feng Zhang; Xu-Shan Wang; Ming Su; Xu Hu; Zheng Sun; Gang Li; Alan Fu; Su Yon Jung; Lina Mu; Na He; Liming Li; Jin-Kou Zhao; Zuo-Feng Zhang
Journal:  Liver Int       Date:  2019-07-10       Impact factor: 5.828

2.  Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.

Authors:  Ling Wei; Yuan Huang; Rongce Zhao; Jing Zhang; Qiuying Liu; Weibo Liang; Xueqin Ding; Bo Gao; Bo Li; Chengjun Sun; Jingyang He; Xiaoqin Yu; Zhongjian Liu; Aimin Sun; Yang Qin
Journal:  Clin Exp Med       Date:  2017-09-26       Impact factor: 3.984

Review 3.  Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside.

Authors:  Bing Hu; Shuang-Shuang Wang; Qin Du
Journal:  World J Hepatol       Date:  2015-05-28

Review 4.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

Review 5.  Disease Burden of Hepatocellular Carcinoma: A Global Perspective.

Authors:  Mehmet Sayiner; Pegah Golabi; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

6.  Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT.

Authors:  Haili Huang; Min Hu; Peng Li; Caijie Lu; Mingyi Li
Journal:  Tumour Biol       Date:  2014-10-15

7.  High expression of HEF1 predicts a poorer prognosis of hepatocellular carcinoma: A retrospective study.

Authors:  Mei Li; Shumei Yan; Muyan Cai; Jiabin Lu; Meifang Zhang; Ping Yang; Rongzhen Luo
Journal:  Mol Clin Oncol       Date:  2015-12-11

Review 8.  Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors.

Authors:  Aileen Baecker; Xing Liu; Carlo La Vecchia; Zuo-Feng Zhang
Journal:  Eur J Cancer Prev       Date:  2018-05       Impact factor: 2.497

9.  microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1).

Authors:  Wei Dai; Hai-Li Huang; Min Hu; Si-Jie Wang; Hui-Juan He; Nian-Pin Chen; Ming-Yi Li
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

10.  Antitumor effects of melanin from Lachnum YM226 and its derivative in H22 tumor-bearing mice.

Authors:  Fang Shi; Jinglei Li; Ziyang Ye; Liuqing Yang; Tingting Chen; Xue Chen; Ming Ye
Journal:  Medchemcomm       Date:  2018-05-16       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.